Grantham, Mayo, Van Otterloo & Co (GMO)’s Rite Aid Corporation RAD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
-178,250
Closed -$15.2M 638
2017
Q1
$15.2M Buy
178,250
+75,870
+74% +$9.14M 0.09% 161
2016
Q4
$16.9M Sell
102,380
-92,077
-47% -$13.9M 0.09% 154
2016
Q3
$29.9M Buy
194,457
+75,327
+63% +$11.2M 0.14% 140
2016
Q2
$17.8M Buy
+119,130
New +$18.8M 0.07% 177
2016
Q1
Sell
-277,030
Closed -$43.4M 641
2015
Q4
$43.4M Buy
+277,030
New +$41M 0.16% 113
2014
Q1
Sell
-7,005
Closed -$709K 660
2013
Q4
$709K Sell
7,005
-62
-0.9% -$6.59K ﹤0.01% 496
2013
Q3
$673K Buy
+7,067
New +$482K ﹤0.01% 504

Other funds holding RAD

Grantham, Mayo, Van Otterloo & Co (GMO)'s RAD Position: Q2 2017 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) sold out of Rite Aid Corporation (RAD) in Q2 2017, closing a stake of 178,250 shares — an estimated $15.2M sold.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in RAD in Q3 2013 and held it in 7 quarters. The position peaked at $43.4M in Q4 2015. 353 funds tracked by Wall St. Rank hold RAD as of Q2 2017.

  • Grantham, Mayo, Van Otterloo & Co (GMO) reported no remaining Rite Aid Corporation position as of Q2 2017 after selling out during the quarter.
  • Grantham, Mayo, Van Otterloo & Co (GMO) sold 178,250 Rite Aid Corporation shares in Q2 2017, an estimated $15.2M.
  • Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in Rite Aid Corporation in Q3 2013 and held it in 7 quarters.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s Rite Aid Corporation position peaked at $43.4M in Q4 2015.
  • 353 funds tracked by Wall St. Rank held Rite Aid Corporation as of Q2 2017.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q2 2017, filed 14 Aug 2017.